Insights

Cutting-edge Therapeutics Parabilis Medicines specializes in developing innovative helical peptide therapeutics targeting traditionally undruggable proteins in cancer treatment. The unique Helicon™ discovery platform creates opportunities to address unmet medical needs, providing a compelling sales angle for potential collaborators and investors.

Strong Financial Backing With over $500 million in funding from prominent life sciences investors, Parabilis Medicines showcases financial stability and growth potential. This solid financial foundation can instill confidence in partners and customers, making it an attractive prospect for sales and strategic partnerships.

Expansive Pipeline Parabilis Medicines boasts a diverse pipeline of first-in-class programs targeting proteins critical in various cancers. This extensive portfolio offers multiple collaboration opportunities for sales expansion, leveraging the company's expertise in developing novel therapies for different cancer types.

Tech-Driven Approach Utilizing cutting-edge technologies such as AI, experimental tools, and data science, Parabilis Medicines accelerates drug discovery and clinical strategy optimization. This tech-savvy approach appeals to tech-oriented companies seeking partnerships, presenting a niche sales avenue for tech integration and collaboration.

Industry Recognition By presenting research findings at prestigious events like ASCO Gastrointestinal Cancers Symposium, Parabilis Medicines enhances its industry reputation and visibility. This recognition can open doors for sales discussions, positioning the company as a key player in cancer therapeutics with significant market influence.

Parabilis Medicines Tech Stack

Parabilis Medicines uses 8 technology products and services including Cloudflare CDN, WordPress, Cloudflare, and more. Explore Parabilis Medicines's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • WordPress
    Content Management System
  • Cloudflare
    Content Management System
  • jQuery
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • Microsoft Azure
    Platform As A Service
  • Python
    Programming Languages
  • Greenhouse
    Recruitment Marketing

Parabilis Medicines's Email Address Formats

Parabilis Medicines uses at least 2 format(s):
Parabilis Medicines Email FormatsExamplePercentage
FLast@fogpharma.comJDoe@fogpharma.com
98%
First.Last@fogpharma.comJohn.Doe@fogpharma.com
1%
FMiddleLast@fogpharma.comJMichaelDoe@fogpharma.com
1%

Frequently Asked Questions

Where is Parabilis Medicines's headquarters located?

Minus sign iconPlus sign icon
Parabilis Medicines's main headquarters is located at 30 Acorn Park Dr Cambridge, MA 02140 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Parabilis Medicines's phone number?

Minus sign iconPlus sign icon
You can contact Parabilis Medicines's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Parabilis Medicines's official website and social media links?

Minus sign iconPlus sign icon
Parabilis Medicines's official website is parabilismed.com and has social profiles on LinkedIn.

How much revenue does Parabilis Medicines generate?

Minus sign iconPlus sign icon
As of December 2024, Parabilis Medicines's annual revenue reached $35M.

What is Parabilis Medicines's SIC code NAICS code?

Minus sign iconPlus sign icon
Parabilis Medicines's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Parabilis Medicines have currently?

Minus sign iconPlus sign icon
As of December 2024, Parabilis Medicines has approximately 160 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief People Officer: K. S.Chief Business Officer: G. M.Chief Data Science Officer: B. A.. Explore Parabilis Medicines's employee directory with LeadIQ.

What industry does Parabilis Medicines belong to?

Minus sign iconPlus sign icon
Parabilis Medicines operates in the Biotechnology Research industry.

What technology does Parabilis Medicines use?

Minus sign iconPlus sign icon
Parabilis Medicines's tech stack includes Cloudflare CDNWordPressCloudflarejQueryMicrosoftMicrosoft AzurePythonGreenhouse.

What is Parabilis Medicines's email format?

Minus sign iconPlus sign icon
Parabilis Medicines's email format typically follows the pattern of . Find more Parabilis Medicines email formats with LeadIQ.

When was Parabilis Medicines founded?

Minus sign iconPlus sign icon
Parabilis Medicines was founded in 2016.
Parabilis Medicines

Parabilis Medicines

Biotechnology ResearchMassachusetts, United States51-200 Employees

Parabilis Medicines™ is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for people living with cancer. Through our pioneering Helicon™ discovery platform, Parabilis is engineering precisely-tuned, stabilized helical peptide therapeutics that have the potential to unlock a large number of traditionally undruggable targets. FOG-001, our first-in-class TCF-blocking β-catenin inhibitor and lead clinical program, is being evaluated in a Phase 1/2 study for patients with colorectal cancer and other solid tumors and is proof of the applicability of our platform to address undruggable intracellular protein-protein targets. We are additionally advancing a pipeline of other first-in-class programs that target proteins known to be relevant to numerous cancers, but considered intractable with traditional drug modalities. The versatility of the Helicon approach allows for the discovery of multiple targeting mechanisms, including functional protein-protein interaction inhibitors, bifunctional degraders, and radioligand therapeutics. We are headquartered in Cambridge, Mass., and are well-capitalized, with more than $500 million raised to date from leading life sciences investors. For more information, please visit: www.parabilismed.com

Section iconCompany Overview

Headquarters
30 Acorn Park Dr Cambridge, MA 02140 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $10M$50M

    Parabilis Medicines's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $10M$50M

    Parabilis Medicines's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.